Literature DB >> 15207901

The activation mechanism of class-C G-protein coupled receptors.

J-P Pin1, J Kniazeff, C Goudet, A-S Bessis, J Liu, T Galvez, F Acher, P Rondard, L Prézeau.   

Abstract

Class-C G-protein coupled receptors (GPCRs) represent a distant group among the large family of GPCRs. This class includes the receptors for the main neurotransmitters, glutamate and gamma-aminobutyric acid (GABA), and the receptors for Ca(2+), some taste and pheromone molecules, as well as some orphan receptors. Like any other GPCRs, class-C receptors possess a heptahelical domain (HD) involved in heterotrimeric G-protein activation, but most of them also have a large extracellular domain (ECD) responsible for agonist recognition and binding. In addition, it is now well accepted that these receptors are dimers, either homo or heterodimers. This complex architecture raises a number of important questions. Here we will discuss our view of how agonist binding within the large ECD triggers the necessary change of conformation, or stabilize a specific conformation, of the heptahelical domain leading to G-protein activation. How ligands acting within the heptahelical domain can change the properties of these complex macromolecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207901     DOI: 10.1016/j.biolcel.2004.03.005

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  29 in total

1.  Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7.

Authors:  C Ullmer; S Zoffmann; B Bohrmann; H Matile; L Lindemann; Pj Flor; P Malherbe
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 2.  Therapeutic antibodies directed at G protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; Fiona H Marshall
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

3.  Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators.

Authors:  Cyril Goudet; Julie Kniazeff; Veronika Hlavackova; Fanny Malhaire; Damien Maurel; Francine Acher; Jaroslav Blahos; Laurent Prézeau; Jean-Philippe Pin
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

Review 4.  G protein coupled receptor structure and activation.

Authors:  Brian K Kobilka
Journal:  Biochim Biophys Acta       Date:  2006-11-15

5.  Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors.

Authors:  Virginie Binet; Béatrice Duthey; Jennifer Lecaillon; Claire Vol; Julie Quoyer; Gilles Labesse; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

6.  Group I mGluRs and long-term depression: potential roles in addiction?

Authors:  Brad A Grueter; Zoé A McElligott; Danny G Winder
Journal:  Mol Neurobiol       Date:  2007-07-27       Impact factor: 5.590

Review 7.  The impact of GPCR structures on pharmacology and structure-based drug design.

Authors:  Miles Congreve; Fiona Marshall
Journal:  Br J Pharmacol       Date:  2009-11-13       Impact factor: 8.739

Review 8.  Mechanisms of multimodal sensing by extracellular Ca(2+)-sensing receptors: a domain-based survey of requirements for binding and signalling.

Authors:  Mahvash A Khan; Arthur D Conigrave
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

9.  Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.

Authors:  Adolfo Rivero-Müller; Yen-Yin Chou; Inhae Ji; Svetlana Lajic; Aylin C Hanyaloglu; Kim Jonas; Nafis Rahman; Tae H Ji; Ilpo Huhtaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

10.  Evolution of the class C GPCR Venus flytrap modules involved positive selected functional divergence.

Authors:  Jianhua Cao; Siluo Huang; Ji Qian; Jinlin Huang; Li Jin; Zhixi Su; Ji Yang; Jianfeng Liu
Journal:  BMC Evol Biol       Date:  2009-03-27       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.